I-MAB (IMAB)
1.80
-0.01
(-0.55%)
USD |
NASDAQ |
Apr 26, 16:00
1.805
0.00 (0.00%)
After-Hours: 20:00
I-MAB Debt to Equity Ratio: 0.0174 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0174 |
| June 30, 2023 | 0.0122 |
| December 31, 2022 | 0.0065 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| June 30, 2020 | 0.0406 |
| June 30, 2019 | -0.0807 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0807
Minimum
Jun 2019
0.0406
Maximum
Jun 2020
-0.0005
Average
0.0032
Median
Debt to Equity Ratio Benchmarks
| Zai Lab Ltd | 0.00 |
| WuXi Biologics (Cayman) Inc | 0.0532 |
| Wuxi AppTec Co Ltd | 0.0843 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Sinovac Biotech Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 484.12M |
| Total Liabilities (Quarterly) | 146.81M |
| Shareholders Equity (Quarterly) | 337.31M |
| Current Ratio | 5.674 |
| Net Debt Paydown Yield | -0.90% |